Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (151-160 of 411) with videos related to

Pageof 42
Sort By:
Journal of Alzheimer'S Disease : JAD|August 5, 2017
Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's DiseaseEnrica Cavedo, Per Suppa, Catharina Lange, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's DiseaseFederica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's diseaseStefan Förster, Verena C Buschert, Stefan J Teipel, et al.
Plos One|January 4, 2021
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Ageing Research Reviews|June 21, 2020
Exercise benefits on Alzheimer's disease: State-of-the-sciencePedro L Valenzuela, Adrián Castillo-García, Javier S Morales, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2013
The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's diseaseVanja Kljajevic, Peter Meyer, Carsten Holzmann, et al.
Neurobiology of Aging|June 15, 2010
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's diseaseWalter Koch, Stephan Teipel, Sophia Mueller, et al.
Human Brain Mapping|July 31, 2010
The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI studyStefan J Teipel, Thomas Meindl, Lea Grinberg, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 14, 2006
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry studyDjyldyz Sydykova, Robert Stahl, Olaf Dietrich, et al.
Nature Reviews. Neurology|October 10, 2018
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinicHarald Hampel, Sid E O'Bryant, José L Molinuevo, et al.
Pageof 42

Showing results (151-160 of 411) with videos related to

Sort By:
Pageof 42
Journal of Alzheimer'S Disease : JAD|August 5, 2017
Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's DiseaseEnrica Cavedo, Per Suppa, Catharina Lange, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's DiseaseFederica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's diseaseStefan Förster, Verena C Buschert, Stefan J Teipel, et al.
Plos One|January 4, 2021
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Ageing Research Reviews|June 21, 2020
Exercise benefits on Alzheimer's disease: State-of-the-sciencePedro L Valenzuela, Adrián Castillo-García, Javier S Morales, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2013
The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's diseaseVanja Kljajevic, Peter Meyer, Carsten Holzmann, et al.
Neurobiology of Aging|June 15, 2010
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's diseaseWalter Koch, Stephan Teipel, Sophia Mueller, et al.
Human Brain Mapping|July 31, 2010
The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI studyStefan J Teipel, Thomas Meindl, Lea Grinberg, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 14, 2006
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry studyDjyldyz Sydykova, Robert Stahl, Olaf Dietrich, et al.
Nature Reviews. Neurology|October 10, 2018
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinicHarald Hampel, Sid E O'Bryant, José L Molinuevo, et al.
Pageof 42